President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut the costs associated with prescription drugs.
GSK and Amgen join the TrumpRx platform, a White House-backed initiative aimed at lowering U.S. prescription drug prices and ...
Amgen Inc. AMGN and GSK plc GSK are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer substantial discounts on prescription drugs. This move will ...
MiBolsilloColombia on MSN
Medicare drug costs: The new $2,100 cap explained
As the Centers for Medicare & Medicaid Services adjust regulations for the upcoming fiscal cycle, beneficiaries face a ...
The Inflation Reduction Act (IRA) has reshaped how Medicare covers and reimburses prescription drugs. For the first time, the federal ...
Medicare Part D changes in 2026 include a $2,100 cap, payment plan rules, prior authorization updates, and new pricing shifts ...
Pharmacy benefit managers (PBMs) have used market leverage to demand rebates, which can lead drug manufacturers to increase sticker prices.
The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the pr | ...
President Donald Trump is scheduled to visit Cincinnati on Wednesday to talk up his new prescription drug plan. An Ohio-based expert said there isn’t much novel about it and reporting has shown that ...
Consumers are paying in cash in a hotly competitive marketplace, creating a rare phenomenon for a relatively new class of prescription drugs: falling prices.
It’s why I make a point to do an inventory at least once a year with my spring cleaning. You never know what you’ll catch: a ...
Jayant Mishra said he was approved for a copay card covering $9,450 a year. He didn't realize how fast the money would run out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results